BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 28614736)

  • 1. Nanoparticle-mediated knockdown of DNA repair sensitizes cells to radiotherapy and extends survival in a genetic mouse model of glioblastoma.
    Kievit FM; Wang K; Ozawa T; Tarudji AW; Silber JR; Holland EC; Ellenbogen RG; Zhang M
    Nanomedicine; 2017 Oct; 13(7):2131-2139. PubMed ID: 28614736
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of siRNA-loaded chitosan nanoparticles targeting Galectin-1 for the treatment of glioblastoma multiforme via intranasal administration.
    Van Woensel M; Wauthoz N; Rosière R; Mathieu V; Kiss R; Lefranc F; Steelant B; Dilissen E; Van Gool SW; Mathivet T; Gerhardt H; Amighi K; De Vleeschouwer S
    J Control Release; 2016 Apr; 227():71-81. PubMed ID: 26902800
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nanoparticle mediated silencing of DNA repair sensitizes pediatric brain tumor cells to γ-irradiation.
    Kievit FM; Stephen ZR; Wang K; Dayringer CJ; Sham JG; Ellenbogen RG; Silber JR; Zhang M
    Mol Oncol; 2015 Jun; 9(6):1071-80. PubMed ID: 25681012
    [TBL] [Abstract][Full Text] [Related]  

  • 4. APE1/REF-1 down-regulation enhances the cytotoxic effects of temozolomide in a resistant glioblastoma cell line.
    Montaldi AP; Godoy PR; Sakamoto-Hojo ET
    Mutat Res Genet Toxicol Environ Mutagen; 2015 Nov; 793():19-29. PubMed ID: 26520369
    [TBL] [Abstract][Full Text] [Related]  

  • 5. RNA nanoparticle as a vector for targeted siRNA delivery into glioblastoma mouse model.
    Lee TJ; Haque F; Shu D; Yoo JY; Li H; Yokel RA; Horbinski C; Kim TH; Kim SH; Kwon CH; Nakano I; Kaur B; Guo P; Croce CM
    Oncotarget; 2015 Jun; 6(17):14766-76. PubMed ID: 25885522
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Localized RNAi therapeutics of chemoresistant grade IV glioma using hyaluronan-grafted lipid-based nanoparticles.
    Cohen ZR; Ramishetti S; Peshes-Yaloz N; Goldsmith M; Wohl A; Zibly Z; Peer D
    ACS Nano; 2015 Feb; 9(2):1581-91. PubMed ID: 25558928
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MiRNA-21 silencing mediated by tumor-targeted nanoparticles combined with sunitinib: A new multimodal gene therapy approach for glioblastoma.
    Costa PM; Cardoso AL; Custódia C; Cunha P; Pereira de Almeida L; Pedroso de Lima MC
    J Control Release; 2015 Jun; 207():31-9. PubMed ID: 25861727
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ShRNA-based POLD2 expression knockdown sensitizes glioblastoma to DNA-Damaging therapeutics.
    Xu Q; Hu C; Zhu Y; Wang K; Lal B; Li L; Tang J; Wei S; Huang G; Xia S; Lv S; Laterra J; Jiang Y; Li Y
    Cancer Lett; 2020 Jul; 482():126-135. PubMed ID: 31954770
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Silencing of DNA repair sensitizes pediatric brain tumor cells to γ-irradiation using gold nanoparticles.
    Liu Z; Yan H; Li H
    Environ Toxicol Pharmacol; 2017 Jul; 53():40-45. PubMed ID: 28501783
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nanoparticle engineered TRAIL-overexpressing adipose-derived stem cells target and eradicate glioblastoma via intracranial delivery.
    Jiang X; Fitch S; Wang C; Wilson C; Li J; Grant GA; Yang F
    Proc Natl Acad Sci U S A; 2016 Nov; 113(48):13857-13862. PubMed ID: 27849590
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel Strategies for Nanoparticle-Based Radiosensitization in Glioblastoma.
    Ruiz-Garcia H; Ramirez-Loera C; Malouff TD; Seneviratne DS; Palmer JD; Trifiletti DM
    Int J Mol Sci; 2021 Sep; 22(18):. PubMed ID: 34575840
    [TBL] [Abstract][Full Text] [Related]  

  • 12. RNA interference for glioblastoma therapy: Innovation ladder from the bench to clinical trials.
    Lozada-Delgado EL; Grafals-Ruiz N; Vivas-Mejía PE
    Life Sci; 2017 Nov; 188():26-36. PubMed ID: 28864225
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Radiation-Induced Targeted Nanoparticle-Based Gene Delivery for Brain Tumor Therapy.
    Erel-Akbaba G; Carvalho LA; Tian T; Zinter M; Akbaba H; Obeid PJ; Chiocca EA; Weissleder R; Kantarci AG; Tannous BA
    ACS Nano; 2019 Apr; 13(4):4028-4040. PubMed ID: 30916923
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cancer-selective nanoparticles for combinatorial siRNA delivery to primary human GBM in vitro and in vivo.
    Kozielski KL; Ruiz-Valls A; Tzeng SY; Guerrero-Cázares H; Rui Y; Li Y; Vaughan HJ; Gionet-Gonzales M; Vantucci C; Kim J; Schiapparelli P; Al-Kharboosh R; Quiñones-Hinojosa A; Green JJ
    Biomaterials; 2019 Jul; 209():79-87. PubMed ID: 31026613
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chimeric adenoviral vector Ad5/F35-mediated APE1 siRNA enhances sensitivity of human colorectal cancer cells to radiotherapy in vitro and in vivo.
    Xiang DB; Chen ZT; Wang D; Li MX; Xie JY; Zhang YS; Qing Y; Li ZP; Xie J
    Cancer Gene Ther; 2008 Oct; 15(10):625-35. PubMed ID: 18535621
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New role of osteopontin in DNA repair and impact on human glioblastoma radiosensitivity.
    Henry A; Nokin MJ; Leroi N; Lallemand F; Lambert J; Goffart N; Roncarati P; Bianchi E; Peixoto P; Blomme A; Turtoi A; Peulen O; Habraken Y; Scholtes F; Martinive P; Delvenne P; Rogister B; Castronovo V; Bellahcène A
    Oncotarget; 2016 Sep; 7(39):63708-63721. PubMed ID: 27563812
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Brain Targeted Gold Liposomes Improve RNAi Delivery for Glioblastoma.
    Grafals-Ruiz N; Rios-Vicil CI; Lozada-Delgado EL; Quiñones-Díaz BI; Noriega-Rivera RA; Martínez-Zayas G; Santana-Rivera Y; Santiago-Sánchez GS; Valiyeva F; Vivas-Mejía PE
    Int J Nanomedicine; 2020; 15():2809-2828. PubMed ID: 32368056
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Theranostic nanoparticles enhance the response of glioblastomas to radiation.
    Wu W; Klockow JL; Mohanty S; Ku KS; Aghighi M; Melemenidis S; Chen Z; Li K; Morais GR; Zhao N; Schlegel J; Graves EE; Rao J; Loadman PM; Falconer RA; Mukherjee S; Chin FT; Daldrup-Link HE
    Nanotheranostics; 2019; 3(4):299-310. PubMed ID: 31723547
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Spherical nucleic acid nanoparticle conjugates as an RNAi-based therapy for glioblastoma.
    Jensen SA; Day ES; Ko CH; Hurley LA; Luciano JP; Kouri FM; Merkel TJ; Luthi AJ; Patel PC; Cutler JI; Daniel WL; Scott AW; Rotz MW; Meade TJ; Giljohann DA; Mirkin CA; Stegh AH
    Sci Transl Med; 2013 Oct; 5(209):209ra152. PubMed ID: 24174328
    [TBL] [Abstract][Full Text] [Related]  

  • 20. RNA interference-mediated gene silencing of pleiotrophin through polyethylenimine-complexed small interfering RNAs in vivo exerts antitumoral effects in glioblastoma xenografts.
    Grzelinski M; Urban-Klein B; Martens T; Lamszus K; Bakowsky U; Höbel S; Czubayko F; Aigner A
    Hum Gene Ther; 2006 Jul; 17(7):751-66. PubMed ID: 16839274
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.